DELATESTRYL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Delatestryl, and when can generic versions of Delatestryl launch?
Delatestryl is a drug marketed by Endo Pharms and is included in one NDA.
The generic ingredient in DELATESTRYL is testosterone enanthate. There are sixty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Delatestryl
A generic version of DELATESTRYL was approved as testosterone enanthate by NEXUS on June 14th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DELATESTRYL?
- What are the global sales for DELATESTRYL?
- What is Average Wholesale Price for DELATESTRYL?
Summary for DELATESTRYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 52 |
| Clinical Trials: | 12 |
| DailyMed Link: | DELATESTRYL at DailyMed |
Recent Clinical Trials for DELATESTRYL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Florida | Phase 2 |
| North Florida/South Georgia Veterans Health System | Phase 2 |
| North Florida Foundation for Research and Education | Phase 2 |
US Patents and Regulatory Information for DELATESTRYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Pharms | DELATESTRYL | testosterone enanthate | INJECTABLE;INJECTION | 009165-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Pharms | DELATESTRYL | testosterone enanthate | INJECTABLE;INJECTION | 009165-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
